Compare Live Nation Entertainment, Inc. (LYV) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs Pfizer Inc — how do they compare? Live Nation Entertainment, Inc. trades at $171.11 (market cap $39.80B), while Pfizer Inc trades at $27.77 (market cap $159.59B). The key difference: Pfizer Inc is far larger — about 4× Live Nation Entertainment, Inc.'s market cap, and Pfizer Inc pays a 6.14% dividend while Live Nation Entertainment, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Live Nation Entertainment, Inc. for 72 Days and Pfizer Inc for 158 Days on average.
| LYV | PFE | |
|---|---|---|
Market Cap | $39.80B | $159.59B |
Volume | 1,162,440 | 30,937,010 |
Sector | Media | Health |
52-Week High | $188.46 | $29.02 |
52-Week Low | $125.61 | $23.67 |
Typical Hold Time | 72 Days | 158 Days |
Enterprise Value | $42.01B | $211.09B |
Dividend Yield | — | 6.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Live Nation Entertainment (LYV) trades at $171.34, down 0.26% on the day, with a bullish technical signal and strong analyst support (87% buy ratings). The company reported mixed Q2 2026 earnings with a beat on EPS but faces valuation concerns with a P/E of 117.5 and negative ROE of -116.7%. Recent news highlights strong consumer demand for live events and strategic partnerships, though regulatory scrutiny and insider selling warrant attention.
The outlook remains positive given robust fan attendance and deferred revenue growth, but high valuation and execution risks in a seasonally heavy Q4 present challenges. Wall Street's $208 price target suggests 21% upside, positioning LYV as a growth play on experiential spending trends with balanced risk-reward dynamics.
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
